<?xml version="1.0" encoding="iso-8859-1"?> 
<rss version="2.0" xmlns:creativeCommons="http://backend.userland.com/creativeCommonsRssModule" 
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" 
xmlns:atom="http://www.w3.org/2005/Atom"
>
<channel>
<title>International Journal of Medical Sciences</title> 
<link>http://www.medsci.org</link> 
<description>International Journal of Medical Sciences RSS feed -- Volume 6</description> 
<language>en-us</language> 
<pubDate>Tue, 20 Nov 2012 04:00:00 GMT</pubDate>
<lastBuildDate>Tue, 20 Nov 2012 04:00:00 GMT</lastBuildDate> 

<item>
<link>http://www.medsci.org/v06p0374.htm</link> 
<title>Campylobacter cholecystitis</title> 
<description><![CDATA[ <p>There are 13 cases of campylobacter cholecystitis reported so far in the medical literature. Among them, only 4 patients had diarrhea. We report another case of acalculous cholecystitis in a setting of campylobacter enteritis. The case report is followed by a literature review regarding this rare condition.</p> ]]></description>  
<dc:creator>Deepak Udayakumar, Mohammed Sanaullah</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>6</prism:number> 
<prism:startingPage>374</prism:startingPage> 
<prism:endingPage>375</prism:endingPage> 
<pubDate>2009-12-1</pubDate>
<category>Case Report</category>
</item>

<item>
<link>http://www.medsci.org/v06p0365.htm</link> 
<title>Autofluorescent Proteins as Photosensitizer in Eukaryontes</title> 
<description><![CDATA[ <p>Since the discovery of the green fluorescent green protein (GFP) in 1961 many variants of fluorescent proteins (FP) were detected. The importance was underlined by the Nobel price award in chemistry 2008 for the invention, application, and development of the GFP by Shimomura, Chalfie and Tsien. GFP, first described by Shimomura now is indispensible in the scientific daily life.</p> <p>Since then and also in future fluorescent proteins will lead to new applications as reporters in cell biology. Such FPs can absorb visible day-light and predominantly one variant of the red fluorescent protein, the KillerRed protein (KRED) emits active electrons producing reactive oxygen species (ROS) leading to photokilling processes in eukaryotes. KRED can be activated by daylight as a photosensitizing agent. It is quite obvious that the KRED's expression and localization is critical with respect to damage, mutation and finally killing of eukaryotic cells. We found evidence that the KRED's cytotoxicity is ascendantly location-dependent from the cell membrane over the nuclear lamina to the chromatin in the cell nucleus. Daylight illumination of cells harbouring the KRED protein fused with the histone H2A, a DNA-binding protein which is critical for the formation of the chromatin structure results in cell killing. Therefore the H2A-KRED fusion protein can be considered as an appropriate candidate for the photodynamic therapy (PDT). This finding can be transferred to current photodynamic approaches and can enhance their therapeutic outcome.</p> ]]></description>  
<dc:creator>Waldemar Waldeck, Gabriele Mueller, Manfred Wiessler, Manuela Brom, Katalin T&#243;th, Klaus Braun</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>6</prism:number> 
<prism:startingPage>365</prism:startingPage> 
<prism:endingPage>373</prism:endingPage> 
<pubDate>2009-12-1</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0358.htm</link> 
<title>980 nm diode lasers in oral and facial practice: current state of the science and art</title> 
<description><![CDATA[ <p><b>Aim:</b> To evaluate the safety and efficacy of a 980nm diode laser for the treatment of benign facial pigmented and vascular lesions, and in oral surgery.</p> <p><b>Materials and Methods:</b> 20 patients were treated with a 980 nm diode laser.</p> <p><i>Oral surgery</i>: 5 patients (5 upper and lower frenulectomy). Fluence levels were 5-15 J/cm<sup>2</sup>; pulse lengths were 20-60 ms; spot size was 1 mm.</p> <p><i>Vascular lesions</i>: 10 patients (5 small angiomas, 5 telangiectases). Fluences were 6-10 J/cm<sup>2</sup>; pulse lengths were 10-50 ms; spot size was 2 mm. In all cases the areas surrounding the lesions were cooled.</p> <p><i>Pigmented lesions</i>: 5 patients (5 keratoses). All the lesions were evaluated by dermatoscopy before the treatment. Fluence levels were 7-15 J/cm<sup>2</sup>; pulse lengths were 20-50 ms; spot size was 1 mm.</p> <p>All the patients were followed at 1, 4 and 8 weeks after the procedure.</p> <p><b>Results:</b> Healing in oral surgery was within 10 days. The melanoses healed completely within four weeks. All the vascular lesions healed after 15 days without any residual scarring.</p> <p><b>Conclusions:</b> The end results for the use of the 980 nm diode laser in oral and facial surgery appears to be justified on the grounds of efficacy and safety of the device, and good degree of acceptance by the patients, without compromising their health and function.</p> ]]></description>  
<dc:creator>Apollonia DESIATE, Stefania CANTORE, Domenica TULLO, Giovanni PROFETA, Felice Roberto GRASSI, Andrea BALLINI</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>6</prism:number> 
<prism:startingPage>358</prism:startingPage> 
<prism:endingPage>364</prism:endingPage> 
<pubDate>2009-11-24</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0348.htm</link> 
<title>Why are some children with early onset of asthma getting better over the years? - Diagnostic failure or salutogenetic factors</title> 
<description><![CDATA[ <p>Among children earlier having been identified with a hospital or primary care diagnosis of asthma at least once between 0-7 years of age, almost 40 % of their parents reported in the ISAAC-questionnaire as never having had asthma (<b>NA</b>). These are further analysed and compared with the persisting asthma cases (<b>A</b>) in this study. All these children's medical records were scrutinized concerning their asthma diagnose retrospectively.</p> <p>The aim of this study was to analyse possible factors related to the outcome in an Asthma diagnosis reassessment by parental questionnaire at the age of ten of the children earlier having been identified with a hospital or primary health care diagnosis of asthma at least once between 0-7 years of age in a total birth-year cohort in a defined Swedish geographical area.</p> <p>A multiple logistic analysis revealed four significant and independent factors associated to the improvement/non-report of asthma at the age of ten. These factors were; not having any past experiences of allergic symptoms (p&#60;0.0001), only having one or two visits at the hospital for asthma diagnosis in the 0-7 interval (p=0.001), not living in a flat but a villa at the age of ten (p=0.029) and no previous perception of mist or mould damage in the house (p=0.052).</p> <p>In the early postnatal stage, obstructive and bronchospastic symptoms typical of asthma may be unspecific, and those cases not continuing to persisting disease tend to have identifiable salutogenetic factors of constitutional rather than environmental nature, namely, an overall reduced allergic predisposition.</p> ]]></description>  
<dc:creator>Eduardo Roel, Olle Zetterstr&#246;m, Erik Trell, Tomas Faresj&#246;</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>6</prism:number> 
<prism:startingPage>348</prism:startingPage> 
<prism:endingPage>357</prism:endingPage> 
<pubDate>2009-11-19</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0338.htm</link> 
<title>High-Resolution Flow Cytometry: a Suitable Tool for Monitoring Aneuploid Prostate Cancer Cells after TMZ and TMZ-BioShuttle Treatment</title> 
<description><![CDATA[ <p>If metastatic prostate cancer gets resistant to antiandrogen therapy, there are few treatment options, because prostate cancer is not very sensitive to cytostatic agents. Temozolomide (TMZ) as an orally applicable chemotherapeutic substance has been proven to be effective and well tolerated with occasional moderate toxicity especially for brain tumors and an application to prostate cancer cells seemed to be promising. Unfortunately, TMZ was inefficient in the treatment of symptomatic progressive hormone-refractory prostate cancer (HRPC). The reasons could be a low sensitivity against TMZ the short plasma half-life of TMZ, non-adapted application regimens and additionally, the aneuploid DNA content of prostate cancer cells suggesting different sensitivity against therapeutical interventions e.g. radiation therapy or chemotherapy. Considerations to improve this unsatisfying situation resulted in the realization of higher local TMZ concentrations, sufficient to kill cells regardless of intrinsic cellular sensitivity and cell DNA-index. Therefore, we reformulated the TMZ by ligation to a peptide-based carrier system called TMZ-BioShuttle for intervention. The modular-composed carrier consists of a transmembrane transporter (CPP), connected to a nuclear localization sequence (NLS) cleavably-bound, which in turn was coupled with TMZ. The NLS-sequence allows an active delivery of the TMZ into the cell nucleus after transmembrane passage of the TMZ-BioShuttle and intra-cytoplasm enzymatic cleavage and separation from the CPP. This TMZ-BioShuttle could contribute to improve therapeutic options exemplified by the hormone refractory prostate cancer. The next step was to syllogize a qualified method monitoring cell toxic effects in a high sensitivity under consideration of the ploidy status. The high-resolution flow cytometric analysis showed to be an appropriate system for a better detection and distinction of several cell populations dependent on their different DNA-indices as well as changes in proliferation of cell populations after chemotherapeutical treatment.</p> ]]></description>  
<dc:creator>Klaus Braun, Volker Ehemann, Manfred Wiessler, Ruediger Pipkorn, Bernd Didinger, Gabriele Mueller, Waldemar Waldeck</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>6</prism:number> 
<prism:startingPage>338</prism:startingPage> 
<prism:endingPage>347</prism:endingPage> 
<pubDate>2009-11-18</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0329.htm</link> 
<title>Comparative study of control selection in a national population -based case-control study: Estimating risk of smoking on cancer deaths in Chinese men</title> 
<description><![CDATA[ <p><b>Purpose</b>: To assess the validation of a novel control selection design by comparing the consistency between the new design and a routine design in a large case-control study that was incorporated into a nationwide mortality survey in China.</p> <p><b>Methods:</b> A nationwide mortality study was conducted during 1989-1991. Surviving spouses or other relatives of all adults who died during 1986-1988 provided detailed information about their own as well as the deceased person's smoking history. In this study, 130,079 males who died of various smoking-related cancers at age 35 or over were taken as cases, while 103,248 male surviving spouses (same age range with cases) of women who died during the same period and 49,331 males who died from causes other than those related to smoking were used as control group 1 and control group 2, respectively. Consistency in the results when comparing cases with each of the control groups was assessed.</p> <p><b>Results: </b>Consistency in the results was observed in the analyses using different control groups although cancer deaths varied with region and age. Equivalence could be ascertained using a 15% criterion in most cancer deaths which had high death rates in urban areas, but they were uncertain for most cancers in rural areas irrespective of whether the hypothesis testing showed significant differences or not.</p> <p><b>Conclusions: </b>Sex-matched living spouse control design as an alternative control selection for a case-control study is valid and feasible, and the basic principles of the equivalence study are also supported by epidemiological survey data.</p> ]]></description>  
<dc:creator>Jingmei Jiang, Boqi Liu, Philip C. Nasca, Wei Han, Xiaonong Zou, Xianjia Zeng, Xiaobing Tian, Yanping Wu, Ping Zhao, Junyao Li</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>6</prism:number> 
<prism:startingPage>329</prism:startingPage> 
<prism:endingPage>337</prism:endingPage> 
<pubDate>2009-10-28</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0322.htm</link> 
<title>Foreign body aspirations in Infancy: a 20-year experience</title> 
<description><![CDATA[ <p><b>Objective</b>: Foreign body aspirations comprise the majority of accidental deaths in childhood. Diagnostic delay may cause an increase in mortality and morbidity in cases without acute respiratory failure. We report our diagnostic and compare the relevant studies available in literature to our results.</p> <p><b>Methods</b>: In our Hospital, bronchoscopy was performed on 1015 patients with the diagnosis of foreign body aspirations (from 1998 to 2008). Of these cases, 63.5% were male and 36.5% female. Their ages ranged from 2 months to 9 years (mean 2.3 years). Diagnosis was made on history, physical examination, radiological methods and bronchoscopy.</p> <p><b>Results</b>: Foreign bodies were localized in the right main bronchus in 560 (55.1%) patients followed by left main bronchus in 191 (18.8%), trachea in 173 (17.1%), vocal cord in 75(7.4%) and both bronchus in 16 (1.6%). Foreign body was not found during bronchoscopy in 48 cases (8.7%). The majority of the foreign bodies were seeds. Foreign bodies were removed with bronchoscopy in all cases. Pneumonia occurs in only 2.9% (29/1015) patients out of our cases<b>.</b></p> <p><b>Conclusion</b>: Rigid bronchoscopy is very effective procedure for inhaled foreign body removal with fewer complications. Proper use of diagnostic techniques provides a high degree of success, and the treatment modality to be used depending on the type of the foreign body is mostly satisfactory.</p> ]]></description>  
<dc:creator>Nader Saki, Soheila Nikakhlagh, Fakher Rahim, Hassan Abshirini</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>6</prism:number> 
<prism:startingPage>322</prism:startingPage> 
<prism:endingPage>328</prism:endingPage> 
<pubDate>2009-10-14</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0312.htm</link> 
<title>Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial</title> 
<description><![CDATA[ <p>Previous studies have shown that undenatured type II collagen (UC-II) is effective in the treatment of rheumatoid arthritis, and preliminary human and animal trials have shown it to be effective in treating osteoarthritis (OA). The present clinical trial evaluated the safety and efficacy of UC-II as compared to a combination of glucosamine and chondroitin (G+C) in the treatment of OA of the knee. The results indicate that UC-II treatment was more efficacious resulting in a significant reduction in all assessments from the baseline at 90 days; whereas, this effect was not observed in G+C treatment group. Specifically, although both treatments reduced the Western Ontario McMaster Osteoarthritis Index (WOMAC) score, treatment with UC-II reduced the WOMAC score by 33% as compared to 14% in G+C treated group after 90 days. Similar results were obtained for visual analog scale (VAS) scores. Although both the treatments reduced the VAS score, UC-II treatment decreased VAS score by 40% after 90 days as compared to 15.4% in G+C treated group. The Lequesne's functional index was used to determine the effect of different treatments on pain during daily activities. Treatment with UC-II reduced Lequesne's functional index score by 20% as compared to 6% in G+C treated group at the end of 90-day treatment. Thus, UC-II treated subjects showed significant enhancement in daily activities suggesting an improvement in their quality of life.</p> ]]></description>  
<dc:creator>David C. Crowley, Francis C. Lau, Prachi Sharma, Malkanthi Evans, Najla Guthrie, Manashi Bagchi, Debasis Bagchi, Dipak K. Dey, Siba P. Raychaudhuri</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>6</prism:number> 
<prism:startingPage>312</prism:startingPage> 
<prism:endingPage>321</prism:endingPage> 
<pubDate>2009-10-9</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0305.htm</link> 
<title>Replacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma</title> 
<description><![CDATA[ <p><b>Objective:</b> The effects of replacing cisplatin (CDDP) with <i>cis</i>-diammineglycolatoplatinum (nedaplatin, NDP), a second-generation platinum complex, on the pharmacokinetics of 5-fluorouracil (5-FU) were investigated in Japanese patients with esophageal squamous cell carcinoma, who were treated with a definitive 5-FU/CDDP-based chemoradiotherapy.</p> <p><b>Methods:</b> Fifty-six patients were enrolled, 49 treated with CDDP and 7 treated with NDP. A course consisted of continuous infusion of 5-FU at 400 mg/m<sup>2</sup>/day for days 1-5 and 8-12, infusion of CDDP or NDP at 40 mg/m<sup>2</sup>/day on days 1 and 8, and radiation at 2 Gy/day on days 1 to 5, 8 to 12, and 15 to 19, with a second course repeated after a 2-week interval. Plasma concentrations of 5-FU were determined by high performance liquid chromatography at 5 PM on days 3, 10, 38 and45, and at 5 AM on days 4, 11, 39 and 46.</p> <p><b>Results and conclusions:</b> The circadian rhythm in plasma concentrations of 5-FU observed in the case of CDDP was altered when NDP was used instead. The clinical response can be predicted by monitoring plasma concentrations of 5-FU in the CDDP group, but not in the NDP group.</p> ]]></description>  
<dc:creator>Akiko Kuwahara, Motohiro Yamamori, Kohshi Nishiguchi, Tatsuya Okuno, Naoko Chayahara, Ikuya Miki, Takao Tamura, Tsubasa Inokuma, Yoshiji Takemoto, Tsutomu Nakamura, Kazusaburo Kataoka, Toshiyuki Sakaeda</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>6</prism:number> 
<prism:startingPage>305</prism:startingPage> 
<prism:endingPage>311</prism:endingPage> 
<pubDate>2009-9-28</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0301.htm</link> 
<title>A k2A-positive Klebsiella pneumoniae causes liver and brain abscess in a Saint Kitt's man</title> 
<description><![CDATA[ <p><i>Klebsiella pneumoniae </i>isolated in community-acquired pneumonia is increasingly found in primary pyogenic liver abscesses. The presence of <i>magA</i> in <i>K. pneumoniae </i>has been implicated in hypermucoviscosity and virulence of liver abscess isolates. The K2 serotype has also been strongly associated with hypervirulence. We report the isolation of non-<i>magA</i>, K2 <i>K. pneumoniae </i>strain from a liver abscess of a Saint Kitt's man who survived the invasive syndrome.</p> ]]></description>  
<dc:creator>Melissa S. Doud, Reni Grimes-Zeppegno, Enrique Molina, Nancimae Miller, Danajeyan Balachandar, Lisa Schneper, Robert Poppiti, Kalai Mathee</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>6</prism:number> 
<prism:startingPage>301</prism:startingPage> 
<prism:endingPage>304</prism:endingPage> 
<pubDate>2009-9-15</pubDate>
<category>Short Research Communication</category>
</item>

<item>
<link>http://www.medsci.org/v06p0296.htm</link> 
<title>Differentiation of convulsive syncope from epilepsy with an implantable loop recorder</title> 
<description><![CDATA[ <p><b>Introduction</b>: Not all convulsive episodes are due to epilepsy and a number of these have a cardiovascular cause. Failure to identify these patients delays the provision of adequate therapy while at the same time exposes the individual to the risk of injury or death.</p> <p><b>Methods:</b> We report on three patients who suffered from recurrent convulsive episodes, thought to be epileptic in origin, who were refractory to antiseizure therapy. Although each patient had undergone extensive evaluation, no other potential cause of his or her seizure like episodes had been uncovered. In each patient placement of an implantable loop recorder (ILR) demonstrated that their convulsive episodes were due to prolonged periods of cardiac asystole and/or complete heart block. In all patients their convulsive episodes were eliminated by permanent pacemaker implantation.</p> <p><b>Conclusion:</b> In patients with refractory &#8220;seizure' like episodes of convulsive activity of unknown etiology a potential cardiac rhythm disturbance should be considered and can be easily evaluated by ILR placement.</p> ]]></description>  
<dc:creator>Khalil Kanjwal, Beverly Karabin, Yousuf Kanjwal, Blair P Grubb</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>6</prism:number> 
<prism:startingPage>296</prism:startingPage> 
<prism:endingPage>300</prism:endingPage> 
<pubDate>2009-9-15</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0287.htm</link> 
<title>Revision of late periprosthetic infections of total hip endoprostheses: pros and cons of different concepts</title> 
<description><![CDATA[ <p>Many concepts have been devised for the treatment of late periprosthetic infections of total hip prostheses. A two-stage revision with a temporary antibiotic-impregnated cement spacer and a cemented prosthesis appears to be the most preferred procedure although, in recent times, there seems to be a trend towards cementless implants and a shorter period of antibiotic treatment. Because of the differences in procedure, not only between studies but also within studies, it cannot be decided which period of parenteral antibiotic treatment and which spacer period is the most suitable. The fact that comparable rates of success can be achieved with different treatment regimens emphasises the importance of surgical removal of all foreign materials and the radical debridement of all infected and ischaemic tissues and the contribution of these crucial procedures to the successful treatment of late periprosthetic infections.</p> ]]></description>  
<dc:creator>Bernd Fink</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>5</prism:number> 
<prism:startingPage>287</prism:startingPage> 
<prism:endingPage>295</prism:endingPage> 
<pubDate>2009-9-4</pubDate>
<category>Review</category>
</item>

<item>
<link>http://www.medsci.org/v06p0280.htm</link> 
<title>Mechanical behaviour of standardized, endoskeleton-including hip spacers implanted into composite femurs</title> 
<description><![CDATA[ <p>Two-stage reconstruction using an antibiotic loaded cement spacer is the preferred treatment method of late hip joint infections. Hip spacers maintain stability of the joint and length of the limb during treatment period. However, as the material strength of bone cement (PMMA) is limited, spacer fractures led to serious complications in the past. This study investigated the load capacity of custom made hip spacers, developed at the 'Klinik f&#252;r Orthop&#228;die und Orthop&#228;dische Chirurgie' (Universit&#228;tsklinikum des Saarlandes, Homburg / Saar, Germany), and implanted into composite femurs. In a quasi-static test, non-reinforced spacers tolerated hip joint loads of about 3000 N, whereas reinforced spacers with titanium-grade-two endoskeletons doubled this load up to 6000 N. Even for cyclic loading, endoskeleton-including hip spacers tolerated loads of &#62;4500 N with 500,000 load cycles. Thus, an endoskeleton-including spacer should provide a mobile and functional joint through the treatment course. A generated FE-model was used to determine the fracture stresses and allows for further sensitivity analysis.</p> ]]></description>  
<dc:creator>T. Thielen, S. Maas, A. Zuerbes, D. Waldmann, K. Anagnostakos, J. Kelm</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>5</prism:number> 
<prism:startingPage>280</prism:startingPage> 
<prism:endingPage>286</prism:endingPage> 
<pubDate>2009-9-3</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0274.htm</link> 
<title>Mechanical complications and reconstruction strategies at the site of hip spacer implantation</title> 
<description><![CDATA[ <p>Over the past two decades antibiotic-impregnated hip spacers have become a popular procedure in the treatment of hip joint infections. Besides infection persistence and/or reinfection, major complications after hip spacer implantation include spacer fracture, -dislocation, and bone fracture. Moreover, in cases with extensive loss of femoral and/or acetabular bone alternative reconstructive techniques should be used for a stable spacer fixation and prevention of fractures or dislocations. The present article reviews the different types of spacer fractures and dislocations and offers some suggestions about reconstructive techniques for management of extensive loss of femoral and/or acetabular bone at the site of hip spacer implantation.</p> ]]></description>  
<dc:creator>Konstantinos Anagnostakos, Jochen Jung, Nora Verena Schmid, Eduard Schmitt, Jens Kelm</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>5</prism:number> 
<prism:startingPage>274</prism:startingPage> 
<prism:endingPage>279</prism:endingPage> 
<pubDate>2009-9-3</pubDate>
<category>Review</category>
</item>

<item>
<link>http://www.medsci.org/v06p0265.htm</link> 
<title>Complications after spacer implantation in the treatment of hip joint infections</title> 
<description><![CDATA[ <p>The aim of this retrospective study was to identify and evaluate complications after hip spacer implantation other than reinfection and/or infection persistence.</p> <p>Between 1999 and 2008, 88 hip spacer implantations in 82 patients have been performed. There were 43 male and 39 female patients at a mean age of 70 [43 - 89] years. The mean spacer implantation time was 90 [14-1460] days. The mean follow-up was 54 [7-96] months. The most common identified organisms were S. aureus and S. epidermidis. In most cases, the spacers were impregnated with 1 g gentamicin and 4 g vancomycin / 80 g bone cement.</p> <p>The overall complication rate was 58.5 % (48/82 cases). A spacer dislocation occurred in 15 cases (17 %). Spacer fractures could be noticed in 9 cases (10.2 %). Femoral fractures occurred in 12 cases (13.6 %). After prosthesis reimplantation, 16 patients suffered from a prosthesis dislocation (23 %). 2 patients (2.4 %) showed allergic reactions against the intravenous antibiotic therapy. An acute renal failure occurred in 5 cases (6 %). No cases of hepatic failure or ototoxicity could be observed in our collective. General complications (consisting mostly of draining sinus, pneumonia, cardiopulmonary decompensation, lower urinary tract infections) occurred in 38 patients (46.3 %).</p> <p>Despite the retrospective study design and the limited possibility of interpreting these findings and their causes, this rate indicates that patients suffering from late hip joint infections and being treated with a two-stage protocol are prone to having complications. Orthopaedic surgeons should be aware of these complications and their treatment options and focus on the early diagnosis for prevention of further complications. Between stages, an interdisciplinary cooperation with other facilities (internal medicine, microbiologists) should be aimed for patients with several comorbidities for optimizing their general medical condition.</p> ]]></description>  
<dc:creator>Jochen Jung, Nora Verena Schmid, Jens Kelm, Eduard Schmitt, Konstantinos Anagnostakos</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>5</prism:number> 
<prism:startingPage>265</prism:startingPage> 
<prism:endingPage>273</prism:endingPage> 
<pubDate>2009-9-2</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0258.htm</link> 
<title>Treatment of proximal femur infections with antibiotic-loaded cement spacers</title> 
<description><![CDATA[ <p>In case of periprosthetic hip infections the implantation of antibiotic-loaded PMMA spacers is accepted for an adequate treatment option. Although their indication for the treatment of destructive, bacterial infections of the proximal femur would make sense, literature data are scarce. Hence, the aim of this study was to evaluate the efficacy of antibiotic-impregnated spacers in the treatment of proximal femur infections.</p> <p>In 10 consecutive patients (5 M/ 5 F, mean age 66 y.) with bacterial proximal femur infections, a femoral head/neck resection was prospectively performed with a subsequent implantation of an antibiotic-loaded spacer. The joint-specific outcome was evaluated by the Merle d&#180;Aubigne and the Mayo hip score, the general outcome by SF-36. The time periods were divided into &#8220;infection situation&#8221;, &#8220;between stages&#8221; and meanly 1 year &#8220;after prosthesis implantation&#8221;.</p> <p>The spacers were meanly implanted over 90 [155-744] days. In all cases an infection eradication could be achieved. After infection eradication, a prosthesis implantation was performed in 8 cases. The general scores showed significant increases at each time period. With regard to the dimension &#8220;pain&#8221;, both scores demonstrated a significant increase between &#8220;infection situation&#8221; and &#8220;between stages&#8221;, but no significance between &#8220;between stages&#8221; and &#8220;after prosthesis implantation&#8221;.</p> <p>Spacers could be indicated in the treatment of proximal femur infections. Besides an infection eradication, a pain reduction is also possible.</p> ]]></description>  
<dc:creator>J. Kelm, P. Bohrer, E. Schmitt, K. Anagnostakos</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>5</prism:number> 
<prism:startingPage>258</prism:startingPage> 
<prism:endingPage>264</prism:endingPage> 
<pubDate>2009-9-3</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0253.htm</link> 
<title>Two-stage procedure in the treatment of late chronic hip infections - spacer implantation</title> 
<description><![CDATA[ <p>Infection after total hip arthroplasties (THA) is a devastating complication with significant consequences for both the patients and the healthcare systems. In recent times, a two stage procedure using antibiotic-impregnated interim spacers has become the most popular treatment for late chronic hip joint infections after THA with success rates over 90%. In this review, we discuss the different types of spacers used in the treatment of chronically infected THA and conclude that hip spacers are effective in the treatment of hip joint infections.</p> ]]></description>  
<dc:creator>Mohamed Sukeik, Fares S. Haddad</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>5</prism:number> 
<prism:startingPage>253</prism:startingPage> 
<prism:endingPage>257</prism:endingPage> 
<pubDate>2009-9-2</pubDate>
<category>Review</category>
</item>

<item>
<link>http://www.medsci.org/v06p0247.htm</link> 
<title>Rationale for one stage exchange of infected hip replacement using uncemented implants and antibiotic impregnated bone graft</title> 
<description><![CDATA[ <p>Infection of a total hip replacement (THR) is considered a devastating complication, necessitating its complete removal and thorough debridement of the site. It is undoubted that one stage exchange, if successful, would provide the best benefit both for the patient and the society. Still the fear of re-infection dominates the surgeons&#180; decisions and in the majority of cases directs them to multiple stage protocols. However, there is no scientifically based argument for that practice. Successful eradication of infection with two stage procedures is reported to average 80% to 98%. On the other hand a literature review of Jackson and Schmalzried (CORR 2000) summarizing the results of 1,299 infected hip replacements treated with direct exchange (almost exclusively using antibiotic loaded cement), reports of 1,077 (83%) having been successful. The comparable results suggest, that the major factor for a successful outcome with traditional approaches may be found in the quality of surgical debridement and dead space management. Failures in all protocols seem to be caused by small fragments of bacterial colonies remaining after debridement, whereas neither systemic antibiotics nor antibiotic loaded bone cement (PMMA) have been able to improve the situation significantly.</p> <p>Reasons for failure may be found in the limited sensitivity of traditional bacterial culturing and reduced antibiotic susceptibility of involved pathogens, especially considering biofilm formation.</p> <p>Whenever a new prosthesis is implanted into a previously infected site the surgeon must be aware of increased risk of failure, both in single or two stage revisions. Eventual removal therefore should be easy with low risk of additional damage to the bony substance. On the other hand it should also have potential of a good long term result in case of success. Cemented revisions generally show inferior long term results compared to uncemented techniques; the addition of antibiotics to cement reduces its biomechanical properties. Efficient cementing techniques will result in tight bonding with the underlying bone, making eventual removal time consuming and possibly associated with further damage to the osseous structures. All these issues are likely to make uncemented revisions more desirable.</p> <p>Allograft bone may be impregnated with high loads of antibiotics using special incubation techniques. The storage capacities and pharmacological kinetics of the resulting antibiotic bone compound (ABC) are more advantageous than the ones of antibiotic loaded cement. ABC provides local concentrations exceeding those of cement by more than a 100fold and efficient release is prolonged for several weeks. The same time they are likely to restore bone stock, which usually is compromised after removal of an infected endoprosthesis. ABC may be combined with uncemented implants for improved long term results and easy removal in case of a failure. Specifications of appropriate designs are outlined.</p> <p>Based on these considerations new protocols for one stage exchange of infected TJR have been established. Bone voids surrounding the implants may be filled with antibiotic impregnated bone graft; uncemented implants may be fixed in original bone. Recent studies indicate an overall success rate of more than 90% without any adverse side effects. Incorporation of allografts appears as after grafting with unimpregnated bone grafts.</p> <p>Antibiotic loaded bone graft seems to provide sufficient local antibiosis for protection against colonisation of uncemented implants, the eluted amounts of antibiotics are likely to eliminate biofilm remnants, dead space management is more complete and defects may be reconstructed efficiently. Uncemented implants provide improved long term results in case of success and facilitated re-revision in case of failure. One stage revision using ABC together with uncemented implants such should be at least comparably save as multiple stage procedures, taking advantage of the obvious benefits for patients and economy.</p> ]]></description>  
<dc:creator>Heinz Winkler</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>5</prism:number> 
<prism:startingPage>247</prism:startingPage> 
<prism:endingPage>252</prism:endingPage> 
<pubDate>2009-9-4</pubDate>
<category>Review</category>
</item>

<item>
<link>http://www.medsci.org/v06p0241.htm</link> 
<title>Vacuum-assisted closure in the treatment of early hip joint infections</title> 
<description><![CDATA[ <p>The aim of the present study was to evaluate the efficacy of the vacuum-assisted closure (V.A.C.) system in the treatment of early hip joint infections. 28 patients (11 m / 17 f; mean age 71 y. [43-84]) with early hip joint infections have been treated by means of the V.A.C.-therapy. At least one surgical revision [1-7] has been unsuccessfully performed for infection treatment prior to V.A.C. - application. Pathogen organisms could have been isolated in 22/28 wounds. During revision, cup inlay and prosthesis head have been exchanged and 1-3 polyvinylalcohol sponges inserted into the wound cavity/ periprosthetically at an initial continuous pressure of 200 mm Hg. Postoperatively, a systemic antibiosis was given according to antibiogram. 48-72 h after surgery an alteration from haemorrhagic to serous fluid was observed in the V.A.C.-canister. Afterwards, the pressure was decreased to 150 mm Hg and remained at this level till sponge removal. After a mean period of 9 [3-16] days the inflammation parameters have been retrogressive and the sponges were removed. An infection eradication could be achieved in 26/28 cases. In the two remaining cases the infected prosthesis had to be explanted and a gentamicin-vancomycin-loaded spacer has been implanted, respectively. At a total mean follow-up of 36 [12-87] months no reinfection or infection persistence was observed. The V.A.C.-system can be a valuable contribution in the treatment of early joint infections when properly used. Indications should be early infections with well-maintained soft-tissues for retention of the negative atmospheric pressure.</p> ]]></description>  
<dc:creator>Jens Kelm, Eduard Schmitt, Konstantinos Anagnostakos</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>5</prism:number> 
<prism:startingPage>241</prism:startingPage> 
<prism:endingPage>246</prism:endingPage> 
<pubDate>2009-9-2</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0234.htm</link> 
<title>Pathogenic organisms in hip joint infections</title> 
<description><![CDATA[ <p>Infections of the hip joint are usually of bacterial etiology. Only rarely, an infectious arthritis is caused in this localization by viruses or fungi. Native joint infections of the hip are less common than infections after implantation of prosthetic devices. Difficulties in prosthetic joint infections are, (I) a higher age of patients, and, thus an associated presence of other medical risk factors, (II) often long courses of treatment regimes depending on the bacterium and its antibiotic resistance, (III) an increased mortality, and (IV) a high economic burden for removal and reimplantation of an infected prosthetic device. The pathogenic mechanisms responsible for articular infections are well studied only for some bacteria, e.g. <i>Staphylococcus aureus</i>, while others are only partially understood. Important known bacterial properties and microbiological characteristics of infection are the bacterial adhesion on the native joint or prosthetic material, the bacterial biofilm formation, the development of small colony variants (SCV) as sessile bacterial types and the increasing resistance to antibiotics.</p> ]]></description>  
<dc:creator>Udo Geipel</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>5</prism:number> 
<prism:startingPage>234</prism:startingPage> 
<prism:endingPage>240</prism:endingPage> 
<pubDate>2009-9-2</pubDate>
<category>Review</category>
</item>

<item>
<link>http://www.medsci.org/v06p0227.htm</link> 
<title>Classification of hip joint infections</title> 
<description><![CDATA[ <p>Infections still remain one of the most devastating complications in hip joint surgery. Classification of these infections help the orthopaedic surgeon to identify the acuteness or chronicity of the infection, predict the complexity of the treatment procedure and ensure that all necessary device are available at the time of the revision surgery. The present article reviews the actual literature and provides an overview of clinical, arthroscopic, microbiological and radiological staging systems.</p> ]]></description>  
<dc:creator>Konstantinos Anagnostakos, Nora Verena Schmid, Jens Kelm, Ulrich Gr&#252;n, Jochen Jung</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>5</prism:number> 
<prism:startingPage>227</prism:startingPage> 
<prism:endingPage>233</prism:endingPage> 
<pubDate>2009-9-1</pubDate>
<category>Review</category>
</item>

<item>
<link>http://www.medsci.org/v06p0224.htm</link> 
<title>Endoscopic thoracic laminoforaminoplasty for the treatment of thoracic radiculopathy: report of 12 cases</title> 
<description><![CDATA[ <p><b>Background</b>: Spinal stenosis of the thoracic spine is less common than that of the cervical and lumbar regions. Due to the close proximity to thoracic and abdominal organs, surgical operations can be difficult and carry a greater risk of complications. The most efficacious intervention for thoracic stenosis, whether central or foraminal, refractory to conservative management is uncertain. We aimed to evaluate the efficacy of endoscopic laminoforaminoplasty (ELFP) in the treatment of thoracic radiculopathy.</p> <p><b>Methods</b>: Twelve patients with radicular pain involving the lower thoracic levels (at or below T6) were treated with ELFP.</p> <p><b>Results</b>: Seven of twelve patients showed marked improvement in pain scores. Average follow-up scores were 2.9 and 12.08 on the Visual Analog Scale (VAS) and Oswestry Disability Index, respectively. The significance was 0.005 between the pre and post surgical data. One patient with moderate symptoms, two with severe symptoms, and two with crippling symptoms did not report significant improvement on VAS or Oswestry. No complications were encountered.</p> <p><b>Conclusions</b>: Endoscopic laminoforaminoplasty offers an alternative to fusion or conventional laminotomy with similar success rates. Patients additionally benefit from a decrease risk of complications, short hospital stay, and faster recovery.</p> ]]></description>  
<dc:creator>Scott M.W. Haufe, Ryan A. Baker, Morgan L. Pyne</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>4</prism:number> 
<prism:startingPage>224</prism:startingPage> 
<prism:endingPage>226</prism:endingPage> 
<pubDate>2009-8-12</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0218.htm</link> 
<title>Effect of corticosteroids on phlebitis induced by intravenous infusion of antineoplastic agents in rabbits</title> 
<description><![CDATA[ <p><b>Purpose: </b>Phlebitis caused by intravenous infusion of antineoplastic agents is one of the critical problems when anticancer therapy is prolonged. We have already reported that both rapid infusion and dilution of the injection solution were effective methods for reducing phlebitis caused by vinorelbine (VNR) in rabbits. The aim of this study was to explore other practical methods for preventing phlebitis caused by VNR and doxorubicin (DXR) in a rabbit model. VNR is often used with cisplatin, and dexamethasone (DEX) has been co-administered for prevention of cisplatin-induced nausea. DXR is used with prednisolone (PSL) in the CHOP regimen for the treatment of non-Hodgkin's lymphoma. Therefore, the present study investigated the prevention of phlebitis due to VNR with DEX and that due to DXR with PSL.</p> <p><b>Methods: </b>VNR and DXR were diluted with normal saline to prepare test solutions at concentrations of 0.6 mg/mL and 1.4 mg/mL, respectively. Each test solution was infused into the auricular veins of rabbits. Two days after VNR infusion and three days after DXR infusion, the veins were evaluated histopathologically. The effect of DEX on VNR-induced phlebitis was evaluated by infusion of DEX before or after VNR. The effect of PSL on DXR-induced phlebitis was similarly evaluated by co-infusion of PSL.</p> <p><b>Results: </b>The histopathological features of phlebitis caused by the antineoplastic agents differed between VNR and DXR: VNR did not cause the loss of venous endothelial cells, but caused inflammatory cell infiltration, edema, and epidermal degeneration. In contrast, DXR caused the loss of venous endothelial cells and chrondrocyte necrosis. Pre-treatment and post-treatment with DEX significantly decreased VNR-induced phlebitis compared with the control group and pre-treatment was particularly effective. Co-infusion of PSL also significantly decreased phlebitis caused by DXR, but its effect was less marked.</p> <p><b>Conclusion</b>: The present findings suggested that pre-treatment with DEX may be a useful method for preventing phlebitis due to VNR, and that co-infusion of PSL has the potential to prevent phlebitis caused by DXR.</p> ]]></description>  
<dc:creator>Emiko Kohno, Saori Murase, Kenji Matsuyama, Noboru Okamura</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>4</prism:number> 
<prism:startingPage>218</prism:startingPage> 
<prism:endingPage>223</prism:endingPage> 
<pubDate>2009-8-6</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0212.htm</link> 
<title>A pilot study of rizatriptan and visually-induced motion sickness in migraineurs</title> 
<description><![CDATA[ <p><b>Background: </b>Limited evidence suggests that rizatriptan given before vestibular stimulation reduces motion sickness in persons with migraine-related dizziness. The present study was designed to test whether rizatriptan is also effective in protecting against visually-induced motion sickness and to test whether rizatriptan blocks the augmentation of motion sickness by head pain.</p> <p><b>Material and Methods: </b>Using randomized double-blind, placebo-controlled methodology, 10 females, 6 with migrainous vertigo (V+) and four without vertigo (V-) received 10 mg rizatriptan or placebo two hours prior to being stimulated by optokinetic stripes. Visual stimulation was coupled with three pain conditions: no pain (N), thermally-induced hand pain (H) and temple pain (T). Motion sickness and subjective discomfort were measured.</p> <p><b>Results: </b>Motion sickness was less after pre-treatment with rizatriptan for 4 of 10 subjects and more for 5 of 10 subjects. Augmentation of motion sickness by head pain was seen in 6 of 10 subjects; this effect was blunted by rizatriptan in 4 of these 6 subjects. Subjective discomfort was significantly more noticeable in V+ subjects as compared with V- subjects.</p> <p><b>Conclusions: </b>These pilot data suggest that rizatriptan does not consistently reduce visually-induced motion sickness in migraineurs. Rizatriptan may diminish motion sickness potentiation by cranial pain.</p> ]]></description>  
<dc:creator>Joseph M. Furman, Dawn A. Marcus</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>4</prism:number> 
<prism:startingPage>212</prism:startingPage> 
<prism:endingPage>217</prism:endingPage> 
<pubDate>2009-8-6</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0200.htm</link> 
<title>Laugh Yourself into a Healthier Person: A Cross Cultural Analysis of the Effects of Varying Levels of Laughter on Health</title> 
<description><![CDATA[ <p>This cross-cultural study explored along with various personality factors the relationship between laughter and disease prevalence. Previous studies have only determined the effect of laughter on various health dimensions, whereas, this study quantified the level of laughter that was beneficial or detrimental to health. There were a total of 730 participants between the ages of eighteen and thirty-nine years. 366 participants were from Aurangabad, India (AUR), and 364 participants were from Mississauga, Canada (MISS). The participants were provided a survey assessing demographics, laughter, lifestyle, subjective well-being, life satisfaction, emotional well-being and health dimensions. In AUR, a beneficial effect of laughter was mediated through moderate levels (level two) of laughter, whereas both low (level one) and high (level three) levels had no effect. Similarly, in MISS, the beneficial effect was mediated through level two, but a negative effect was also seen at level three. This could be attributable to a higher prevalence of bronchial asthma in western countries. Laughter was associated with emotional well-being in MISS and life satisfaction in AUR, providing cross cultural models to describe the interactions between laughter and disease. This study validated the correlation between emotional well-being and life satisfaction, with a stronger correlation seen in MISS, suggesting that individualists rely more on their emotional well-being to judge their life satisfaction. In conclusion, there is a benefit to clinicians to incorporate laughter history into their general medical history taking. Future research should consider developing mechanisms to explain the effects of level two, determine specific systemic effects and obtain more samples to generalize the cross cultural differences.</p> ]]></description>  
<dc:creator>Hunaid Hasan, Tasneem Fatema Hasan</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>4</prism:number> 
<prism:startingPage>200</prism:startingPage> 
<prism:endingPage>211</prism:endingPage> 
<pubDate>2009-7-28</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0192.htm</link> 
<title>OPERATIVE TREATMENT OF TRANSVERSE ACETABULAR FRACTURES: IS IT REALLY NECESSARY TO FIX BOTH COLUMNS?</title> 
<description><![CDATA[ <p><b>Objective:</b> we prospectively evaluated clinical and radiographic outcomes in patients with displaced combined transverse-posterior wall acetabular fractures managed at our Institution over a period of seven years by posterolateral single approach, direct posterior wall and posterior column reduction and plating, and indirect reduction of anterior column controlled by fluoroscopic images with or without lag-screw fixation. The aim was to identify if the obtained immediate postoperative Matta radiographic roof-arc angles after fracture reduction and fixation alters in the postoperative period when comparing posterior plating alone versus posterior plate and anterior column lag-screw fixation. <b>Patients and Methods:</b> 35 skeletally mature patients (31 male and four female, with mean age of 39.9 years old [range, 23.3 to 66.7 y/o]) with combined transverse-posterior wall acetabular fractures surgically treated by a posterolateral single approach were enrolled in this prospective investigation. Nineteen patients had associated orthopaedic injuries. The first part of the acetabular fracture management was similar to all patients and consisted in anatomical reduction and fixation of the transverse posterior component followed by anatomical reduction and fixation of the posterior wall component. The transverse anterior component reduction was controlled by fluoroscopic images (anteroposterior (AP), iliac oblique, and obturator oblique views) and digital palpation through the greater sciatic notch. Fifteen of the 35 patients had an additional lag-screw fixation from the posterior to the anterior columns with an extra-long small-fragment cortical screw. AP and Judet oblique radiographic views were taken at the end of the procedure and roof-arc angles were measured. Clinical results were assigned according to the grading system of Merle D'Aubigne&#180; and Postel as modified by Matta et al. Radiographic roof-arc angles were checked and compared between the two groups of patients to the same data collected both at the time of the surgical procedure and at three months postoperatively. Statistical analysis was done by either using chi-square (clinical outcome) and Mann-Whitney (roentgenographic outcome) tests, with a level of significance of &#945; = 5%. <b>Results</b>: at final follow-up examination 18 to 84 months postoperatively (mean, 46.8 months), the clinical results were considered satisfactory in 31 (88.6%) patients (excellent in nine (25.7%) and good in 22 (62.9%) patients). There was no difference between patients with (n = 15) and without (n = 20) fixation of the transverse anterior component of the acetabular fracture (p = 0.67). Radiographic roof-arc angles measured at discharge, at three months postoperatively and at the last follow-up consultation didn't changed significantly (p &#62; 0.05). There was no statistically significant difference between patients treated with (n = 15) and without (n = 20) fixation of the anterior component of the transverse acetabular fracture in terms of medial displacement of the femoral head. <b>Conclusion</b>: the authors suggest that associated transverse-posterior wall acetabular fractures can be managed by a single posterior approach. Direct reduction and fixation of the posterior wall and column components is an adequate option for these injuries. If there is adequate indirect reduction of the anterior column, as checked by digital palpation and fluoroscopy, we feel that it is not necessary to fix the anterior column component of the transverse acetabular fracture.</p> ]]></description>  
<dc:creator>Vincenzo Giordano, Ney Pecegueiro do Amaral, Alexandre Pallottino, Rodrigo Pires e Albuquerque, Carlos Eduardo Franklin, Pedro Jos&#233; Labronici</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>4</prism:number> 
<prism:startingPage>192</prism:startingPage> 
<prism:endingPage>199</prism:endingPage> 
<pubDate>2009-7-12</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0184.htm</link> 
<title>Comparison of skeletal muscle strength between cardiac patients and age-matched healthy controls</title> 
<description><![CDATA[ <p>The purpose of the present study was to compare muscular strength of knee extensors and arm flexor muscles of cardiac patients (n = 638) and healthy controls (n = 961) in different age groups. Isometric torques were measured in a sitting position with the elbow, hip, and knee flexed to 90<sup>0</sup>. For statistical analysis, age groups were pooled in decades from the age of 30 to 90 years. Additionally, the influence of physical lifestyle prior to disease on muscular strength was obtained in the patients. For statistical analysis three-way ANOVA (factors age, gender, and physical activity level) was used.</p> <p>Both in patients and in controls a significant age-dependent decline in maximal torque could be observed for arm flexors and knee extensors. Maximal leg extensor muscle showed statistically significant differences between healthy controls and cardiac patients as well as between subgroups of patients: Physically inactive patients showed lowest torques (male: 148 &#177; 18 Nm; female: 82 &#177; 25 Nm) while highest values were measured in control subjects (male: 167 &#177; 16 Nm; female: 93 &#177; 17 Nm). In contrast, arm flexor muscles did not show any significant influence of health status or sports history.</p> <p>This qualitative difference between weight-bearing leg muscles and the muscle group of the upper extremity suggest that lower skeletal muscle strength in heart patients is mainly a consequence of selective disuse of leg muscles rather than any pathological skeletal muscle metabolism. Since a certain level of skeletal muscle strength is a prerequisite to cope with everyday activities, strength training is recommended as an important part of cardiac rehabilitation.</p> ]]></description>  
<dc:creator>K. Baum, U. Hildebrandt, K. Edel, R. Bertram, H. Hahmann, F.J. Bremer, S. B&#246;hmen, C. Kammerlander, M. Serafin, Th. R&#252;ther, E. Miche</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>4</prism:number> 
<prism:startingPage>184</prism:startingPage> 
<prism:endingPage>191</prism:endingPage> 
<pubDate>2009-7-6</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0177.htm</link> 
<title>IMMUNE RESPONSES IN AUTOIMMUNE HEPATITIS: EFFECT OF PREDNISONE AND AZATHIOPRINE TREATMENT: CASE REPORT</title> 
<description><![CDATA[ <p>The role of the immune response in autoimmune hepatitis has not been studied before and after prednisone and azathioprine treatment. Distributions of blood lymphocytes (CD4+, CD8+, CD19+, CD23+, CD16/56+), levels of serum immunoglobulins (IgM, IgG, IgE, IgA) and cytokines (IFN-&#947;, IL-4, IL-12, TNF&#945; ) were studied in a child (f/14 y/o) with autoimmune hepatitis before and after prednisone (20 mg/d) and azathioprine (50 mg/d) treatment (nephelometry, UniCAP Total IgE Fluoroenzymeimmunoassay, flow cytometry, cytokine ELISA). Patient was studied for 0-2.5 yrs; treatment was initiated 12 weeks post diagnosis. Numbers of CD4+ T cells increased (50%), while CD19+ and CD23+ cells decreased (&#62;50%) post treatment; other lymphocyte subsets were unaffected by treatment. Serum IgG and IgE levels decreased (&#62;50%) after treatment; serum IgM and IgA were within normal range and were not affected by treatment High levels of IFN-&#947; (5-23 pg/ml) were initially detected in serum, which decreased after treatment (&#60;0.1 pg/ml). Furthermore, low levels of IL-4 (0.2 pg/mL) were detected before treatment, which were not detected after treatment (&#60;0.1 pg/ml). In contrast, before treatment, IL-12 and TNF&#945; were not detected in serum; however after treatment the levels of IL-12 and TNF&#945; dramatically increased. Prednisone and azathioprine treatment decreased total serum IgG, IgE, IFN-&#947; and IL-4 levels, and blood CD19+ and CD23+ cells; however serum IL-12, TNF&#945; and blood CD4+ T cells increased with treatment. Understanding immunomodulation in autoimmune hepatitis will provide better insight and mechanisms of this disease and may tailor more effective therapeutic intervention.</p> ]]></description>  
<dc:creator>Martin H. Bluth, Stephan Kohlhoff, Kevin B. Norowitz, Jonathan I Silverberg, Seto Chice, M Nowakowski, Helen G. Durkin, Tamar A. Smith-Norowitz</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>4</prism:number> 
<prism:startingPage>177</prism:startingPage> 
<prism:endingPage>183</prism:endingPage> 
<pubDate>2009-6-30</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0168.htm</link> 
<title>Elevated Serum Levels of Arachidonoyl-lysophosphatidic Acid and Sphingosine 1-Phosphate in Systemic Sclerosis</title> 
<description><![CDATA[ <p>Systemic sclerosis (SSc) is an often fatal disease characterized by autoimmunity and inflammation, leading to widespread vasculopathy and fibrosis. Lysophosphatidic acid (LPA), a bioactive phospholipid in serum, is generated from lysophospholipids secreted from activated platelets in part by the action of lysophospholipase D (lysoPLD). Sphingosine 1-phosphate (S1P), a member of the bioactive lysophospholipid family, is also released from activated platelets. Because activated platelets are a hallmark of SSc, we wanted to determine whether subjects with SSc have altered serum lysophospholipid levels or lysoPLD activity. Lysophospholipid levels were measured using mass spectrometric analysis. LysoPLD activity was determined by quantifying choline released from exogenous lysophosphatidylcholine (LPC). The major results were that serum levels of arachidonoyl (20:4)-LPA and S1P were significantly higher in SSc subjects versus controls. Furthermore, serum LPA:LPC ratios of two different polyunsaturated phospholipid molecular species, and also the ratio of all species combined, were significantly higher in SSc subjects versus controls. No significant differences were found between other lysophospholipid levels or lysoPLD activities. Elevated 20:4 LPA, S1P levels and polyunsaturated LPA:LPC ratios may be markers for and/or play a significant role in the etiology of SSc and may be future pharmacological targets for SSc treatment.</p> ]]></description>  
<dc:creator>Akira Tokumura, Laura D. Carbone, Yasuko Yoshioka, Junichi Morishige, Masaki Kikuchi, Arnold Postlethwaite, Mitchell A. Watsky</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>4</prism:number> 
<prism:startingPage>168</prism:startingPage> 
<prism:endingPage>176</prism:endingPage> 
<pubDate>2009-6-5</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0160.htm</link> 
<title>Determinants of improvement in quality of life of alcohol-dependent patients during an inpatient withdrawal programme</title> 
<description><![CDATA[ <p><b>Background: </b>To investigate the improvement in quality of life (QoL) of alcohol-dependent patients during a 3-week inpatient withdrawal programme, and to identify the sociodemographic, clinical and alcohol-related variables associated with baseline QoL on admission and with improvement of QoL during residential treatment.</p> <p><b>Methods:</b> This prospective, observational study included 414 alcohol-dependent patients, hospitalised for a period of 3 weeks. QoL was measured on admission and at discharge using the French version of the Medical Outcome Study SF-36. The mean scores for each dimension and for the Physical and Mental Component Summary scores were calculated.</p> <p><b>Results: </b>The mean scores per dimension and the mean Physical and Mental Component Summary scores were significantly lower on admission than at discharge; the lowest scores being observed for social functioning and role limitations due to emotional problems. At discharge, the mean scores per dimension were similar to those observed in the French general population. Female gender, age &#62;45 years, living alone, working as a labourer or employee, somatic comorbidity, and the existence of at least five criteria for alcohol dependence according to the DSM-IV classification were associated with a low Physical Component Summary score on admission; psychiatric comorbidity, the presence of at least five DSM-IV dependence criteria, smoking and suicidality were associated with a low Mental Component Summary score on admission. The increase in Physical and Mental Component Summary scores during hospitalisation was more marked when the initial scores were low. Apart from the initial score, the greatest improvement in Physical Component Summary score was seen in patients with a high alcohol intake and in those without a somatic comorbidity; the increase in Mental Component Summary score was greatest in patients without psychotic symptoms and in those who abused or were dependent on illegal drugs.</p> <p><b>Conclusion:</b> QoL improvement after a residential treatment was related to low QoL scores at admission. Improvement in physical component of QoL was related to baseline alcohol intake and good somatic status. Improvement in mental component of QoL was related to other drugs abuse/dependence.</p> ]]></description>  
<dc:creator>Pierre Lahmek, Ivan Berlin, Laurent Michel, Chafia Berghout, Nadine Meunier, Henri-Jean Aubin</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>4</prism:number> 
<prism:startingPage>160</prism:startingPage> 
<prism:endingPage>167</prism:endingPage> 
<pubDate>2009-5-18</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0156.htm</link> 
<title>Gene expression analysis of human red blood cells</title> 
<description><![CDATA[ <p>Understanding of molecular mechanisms governing the enucleating phenomena of human erythrocytes is of major importance in both fundamental and applied studies. Total RNA (n=7) from human RBCs (purity of erythrocyte preparation &#62;99,99%) was tested using 2100 Bioanalyzer (<i>Agilent</i>, USA), and transcribed to cDNA. Microarray analysis was performed with the Human Genome Focus GeneChip (<i>Affymetrix</i>, USA), containing 8500 transcripts corresponding to 8400 human genes. Here we report that human RBCs contain typical eukaryotic RNA with 28S- and18S-rRNA standard bands. Microarray studies revealed the presence of transcripts of 1019 different genes in erythrocytic RNA. Gene Ontology analysis recognized 859 genes involved in general biological processes: 529 genes for cellular metabolism, 228 genes for signal transduction, 104 genes for development, 107 genes for immune response, 62 genes for protein localization, 53 genes for programmed cell death, and 5 genes for autophagy. A number of genes responsible for transcription, translation, RNA-stabilisation as well as for apoptosis and anti-apoptosis have been identified for the first time in circulating human RBCs. The presented data shed new light on the genetic determination of erythropoiesis, apoptosis and may have implications on the pathophysiology and diagnosis of various diseases involving red blood cells.</p> ]]></description>  
<dc:creator>Sveta Kabanova, Petra Kleinbongard, Jens Volkmer, Birgit Andr&#233;e, Malte Kelm, Thomas W. Jax</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>4</prism:number> 
<prism:startingPage>156</prism:startingPage> 
<prism:endingPage>159</prism:endingPage> 
<pubDate>2009-4-28</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0143.htm</link> 
<title>Comparison of a Two-Lead, Computerized, Resting ECG Signal Analysis Device, the MultiFunction-CardioGramsm or MCG (a.k.a. 3DMP), to Quantitative Coronary Angiography for the Detection of Relevant Coronary Artery Stenosis (&#62;70%) - A Meta-Analysis of all Published Trials Performed and Analyzed in the US</title> 
<description><![CDATA[ <p>Background: Accurate, non-invasive diagnosis of, and screening for, coronary artery disease (CAD) and restenosis after coronary revascularization has been a challenge due to either low sensitivity/specificity or relevant morbidity associated with current diagnostic modalities.</p> <p>Methods: To assess sensitivity and specificity of a new computerized, multiphase, resting electrocardiogram analysis device (MultiFunction-CardioGram<sup>sm</sup> or MCG a.k.a. 3DMP) for the detection of relevant coronary stenosis (&#62;70%), a meta-analysis of three published prospective trials performed in the US on patient data collected using the US manufactured device and analyzed using the US-based software and New York data analysis center from patients in the US, Germany, and Asia was completed. A total of 1076 patients from the three trials (US - 136; Germany - 751; Asia - 189) (average age 62 &#177; 11.5, 65 for women, 60 for men) scheduled for coronary angiography, were included in the analysis. Patients enrolled in the trials may or may not have had prior angiography and/or coronary intervention. Angiographic results in all studies were classified for hemodynamically relevant stenosis (&#62; 70%) by two US based angiographers independently.</p> <p>Results: Hemodynamically relevant stenosis was diagnosed in 467 patients (43.4%). The device, after performing a frequency-domain, computational analysis of the resting ECG leads and computer-database comparison, calculated a coronary ischemia &#8220;severity&#8221; score from 0 to 20 for each patient. The severity score was significantly higher for patients with relevant coronary stenosis (5.4 &#177; 1.8 vs. 1.7 &#177; 2.1). The study device (using a cut-off score for relevant stenosis of 4.0) correctly classified 941 of the 1076 patients with or without relevant stenosis (sensitivity-91.2%; specificity-84.6%; NPV 0.942, PPV 0.777). Adjusted positive and negative predictive values (PPV and NPV) were 81.9% and 92.6%, respectively (ROC AUC = 0.881 [95% CI: 0.860-0.903]). Subgroup analysis showed no significant influence of sex, age, race/nationality, previous revascularization procedures, resting ECG morphology, or participating center on the device's diagnostic performance.</p> <p>Conclusions: The new computerized, multiphase, resting ECG analysis device (MultiFunction-CardioGram<sup>sm</sup>) has been shown in this meta-analysis to safely and accurately identify patients with relevant coronary stenosis (&#62;70%) with high sensitivity and specificity and high negative predictive value. Its potential use in the evaluation of symptomatic patients suspected to suffer from coronary disease/ischemia is discussed.</p> ]]></description>  
<dc:creator>John E. Strobeck, Joseph T. Shen, Binoy Singh, Kotaro Obunai, Charles Miceli, Howard Sacher, Franz Ritucci, Michael Imhoff</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>4</prism:number> 
<prism:startingPage>143</prism:startingPage> 
<prism:endingPage>155</prism:endingPage> 
<pubDate>2009-4-7</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0140.htm</link> 
<title>Update on the treatment of ocular toxoplasmosis</title> 
<description><![CDATA[  ]]></description>  
<dc:creator>Yan Guex-Crosier</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>3</prism:number> 
<prism:startingPage>140</prism:startingPage> 
<prism:endingPage>142</prism:endingPage> 
<pubDate>2009-3-19</pubDate>
<category>Short Communication</category>
</item>

<item>
<link>http://www.medsci.org/v06p0139.htm</link> 
<title>Usefulness of vitrectomy in the treatment of ocular toxoplasmosis</title> 
<description><![CDATA[  ]]></description>  
<dc:creator>Etienne H. Bovey</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>3</prism:number> 
<prism:startingPage>139</prism:startingPage> 
<prism:endingPage>139</prism:endingPage> 
<pubDate>2009-3-19</pubDate>
<category>Short Communication</category>
</item>

<item>
<link>http://www.medsci.org/v06p0137.htm</link> 
<title>Optical Coherence Tomography in ocular toxoplasmosis</title> 
<description><![CDATA[  ]]></description>  
<dc:creator>Dominique Monnet, Kristel Averous, Emmanuelle Delair, Antoine P. Br&#233;zin</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>3</prism:number> 
<prism:startingPage>137</prism:startingPage> 
<prism:endingPage>138</prism:endingPage> 
<pubDate>2009-3-19</pubDate>
<category>Short Communication</category>
</item>

<item>
<link>http://www.medsci.org/v06p0135.htm</link> 
<title>Laboratory diagnosis of Toxoplasma gondii infection</title> 
<description><![CDATA[  ]]></description>  
<dc:creator>A. Calderaro, S. Peruzzi, G. Piccolo, C. Gorrini, S. Montecchini, S. Rossi, C. Chezzi, G. Dettori</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>3</prism:number> 
<prism:startingPage>135</prism:startingPage> 
<prism:endingPage>136</prism:endingPage> 
<pubDate>2009-3-19</pubDate>
<category>Short Communication</category>
</item>

<item>
<link>http://www.medsci.org/v06p0133.htm</link> 
<title>Human toxoplasmosis and the role of veterinary clinicians</title> 
<description><![CDATA[  ]]></description>  
<dc:creator>Laura Kramer</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>3</prism:number> 
<prism:startingPage>133</prism:startingPage> 
<prism:endingPage>134</prism:endingPage> 
<pubDate>2009-3-19</pubDate>
<category>Short Communication</category>
</item>

<item>
<link>http://www.medsci.org/v06p0131.htm</link> 
<title>Ocular Bartonellosis</title> 
<description><![CDATA[  ]]></description>  
<dc:creator>Massimo Accorinti</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>3</prism:number> 
<prism:startingPage>131</prism:startingPage> 
<prism:endingPage>132</prism:endingPage> 
<pubDate>2009-3-19</pubDate>
<category>Short Communication</category>
</item>

<item>
<link>http://www.medsci.org/v06p0129.htm</link> 
<title>Ocular Toxocariasis</title> 
<description><![CDATA[  ]]></description>  
<dc:creator>Paola Pivetti-Pezzi</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>3</prism:number> 
<prism:startingPage>129</prism:startingPage> 
<prism:endingPage>130</prism:endingPage> 
<pubDate>2009-3-19</pubDate>
<category>Short Communication</category>
</item>

<item>
<link>http://www.medsci.org/v06p0128.htm</link> 
<title>Ocular manifestations of Rickettsiosis: 2. Retinal involvement and treatment</title> 
<description><![CDATA[  ]]></description>  
<dc:creator>Leila El Matri</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>3</prism:number> 
<prism:startingPage>128</prism:startingPage> 
<prism:endingPage>128</prism:endingPage> 
<pubDate>2009-3-19</pubDate>
<category>Short Communication</category>
</item>

<item>
<link>http://www.medsci.org/v06p0126.htm</link> 
<title>Ocular Manifestations of Rickettsiosis: 1. Mediterranean Spotted Fever: laboratory analysis and case reports</title> 
<description><![CDATA[  ]]></description>  
<dc:creator>Antonio Pinna</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>3</prism:number> 
<prism:startingPage>126</prism:startingPage> 
<prism:endingPage>127</prism:endingPage> 
<pubDate>2009-3-19</pubDate>
<category>Short Communication</category>
</item>

<item>
<link>http://www.medsci.org/v06p0124.htm</link> 
<title>Ocular manifestations of Lyme borreliosis in Europe</title> 
<description><![CDATA[  ]]></description>  
<dc:creator>Paolo Mora, Arturo Carta</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>3</prism:number> 
<prism:startingPage>124</prism:startingPage> 
<prism:endingPage>125</prism:endingPage> 
<pubDate>2009-3-19</pubDate>
<category>Short Communication</category>
</item>

<item>
<link>http://www.medsci.org/v06p0123.htm</link> 
<title>Local epidemiology and clinical manifestations of Lyme disease</title> 
<description><![CDATA[  ]]></description>  
<dc:creator>Walter O. Pavan</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>3</prism:number> 
<prism:startingPage>123</prism:startingPage> 
<prism:endingPage>123</prism:endingPage> 
<pubDate>2009-3-19</pubDate>
<category>Short Communication</category>
</item>

<item>
<link>http://www.medsci.org/v06p0120.htm</link> 
<title>Introduction into Pathology of Ocular Zoonoses</title> 
<description><![CDATA[  ]]></description>  
<dc:creator>Hans E. Schaefer</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>3</prism:number> 
<prism:startingPage>120</prism:startingPage> 
<prism:endingPage>122</prism:endingPage> 
<pubDate>2009-3-19</pubDate>
<category>Short Communication</category>
</item>

<item>
<link>http://www.medsci.org/v06p0118.htm</link> 
<title>Incidence of Ocular Zoonoses referred to the Inflammatory and Autoimmune Ocular Diseases Service of the University of Parma - Italy</title> 
<description><![CDATA[  ]]></description>  
<dc:creator>Stefania Gonzales, Alessandro Giannone, Pierangela Rubino, Francesca Manzotti, Isabella Pellistri, Paolo Mora, Jelka G. Orsoni</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>3</prism:number> 
<prism:startingPage>118</prism:startingPage> 
<prism:endingPage>119</prism:endingPage> 
<pubDate>2009-3-19</pubDate>
<category>Short Communication</category>
</item>

<item>
<link>http://www.medsci.org/v06p0116.htm</link> 
<title>Introduction to special issue on Eye and Zoonosis - from the guest editors</title> 
<description><![CDATA[ <p>Papers of this special issue are based on the presentations given in the Congress &#8220;Eye and Zoonosis&#8221; - October 10-11<sup>th</sup> 2008, Parma (Italy). This issue aims to provide researchers with timely update on a number of important topics on Zoonosis in Ophthalmology.</p> ]]></description>  
<dc:creator>Jelka G. ORSONI, Paolo MORA</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>3</prism:number> 
<prism:startingPage>116</prism:startingPage> 
<prism:endingPage>117</prism:endingPage> 
<pubDate>2009-3-19</pubDate>
<category>Editorial</category>
</item>

<item>
<link>http://www.medsci.org/v06p0114.htm</link> 
<title>Ocular Manifestations of West Nile Virus Infection</title> 
<description><![CDATA[  ]]></description>  
<dc:creator>Salim Ben Yahia, Moncef Khairallah</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>3</prism:number> 
<prism:startingPage>114</prism:startingPage> 
<prism:endingPage>115</prism:endingPage> 
<pubDate>2009-5-26</pubDate>
<category>Short Communication</category>
</item>

<item>
<link>http://www.medsci.org/v06p0106.htm</link> 
<title>Clinical Symptoms Associated with Asystolic or Bradycardic Responses on Implantable Loop Recorder Monitoring in Patients with Recurrent Syncope</title> 
<description><![CDATA[ <p>Background: Implantable loop recorders (ILR) have been found to be useful in the diagnosis and management of syncope of unclear etiology. The clinical symptoms of abnormalities seen during ILR monitoring have not been adequately studied.</p> <p>Aim: The aim of this retrospective study was to determine the clinical symptoms which were the best predictors of asystolic or bradycardic responses during ILR monitoring.</p> <p>Methods: Patients with either asystole or bradycardia recorded during ILR monitoring were analyzed from our database. The clinical characteristics of these patients were compared to the patients with ILR's who did not have recorded bradycardic episodes. The episodes were characterized as being convulsive or nonconvulsive, brief (&#60;5 minutes) or prolonged (&#62; 5 minutes), and having had a prodrome or no prodrome.</p> <p>Results: Eleven patients (4 males and 7 females; age 39 &#177;11years) had asystole or bradycardia on ILR monitoring. Eleven patients (2 males and 9 females; age 46&#177;23) had no bradycardiac events. Palpitations, convulsive syncope, prolonged episode, and prodrome were present in 37% vs. 74% (P = 0.125), 62% vs. 0% (P = 0.002), 87% vs. 0% (P=0), and 73% vs. 13% (P=0.009) patients, respectively, in the asystole/bradycardia and non-bradycardia groups. In the asystole/bradycardia group eight patients had bradycardia (HR &#60; 20) for &#62; 10 seconds and three patients had asystole &#62;10 seconds.</p> <p>Conclusion: Convulsive syncope, prolonged loss of consciousness during syncopal episode, and absence of prodrome or aura are clinical predictors of asystole or bradycardia on ILR monitoring.</p> ]]></description>  
<dc:creator>Khalil Kanjwal, Yousuf Kanjwal, Beverly Karabin, Blair P. Grubb</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>2</prism:number> 
<prism:startingPage>106</prism:startingPage> 
<prism:endingPage>110</prism:endingPage> 
<pubDate>2009-4-9</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0102.htm</link> 
<title>Endoscopic laminoforaminoplasty success rates for treatment of foraminal spinal stenosis: report on sixty-four cases</title> 
<description><![CDATA[ <p>Background: Foraminal stenosis is an important cause of radicular and generalized back pain. In patients who do not respond to conservative interventions, endoscopic spinal surgery provides similar results to open surgical approaches with lower rates of complication, postoperative pain, and shorter duration of hospital stay.</p> <p>Methods: We performed a prospective, open, uncontrolled trial of 64 patients to evaluate endoscopic laminoforaminoplasty for the treatment of refractory foraminal stenosis.</p> <p>Results: Fifty-nine percent of patients had at least 75% improvement in Oswestry Disability Index (Oswestry) and Visual Analog Scale (VAS) scores. All patients were discharged the day of surgery. Dural leaks occurred in two patients, which were repaired intraoperatively. No other adverse events occurred.</p> <p>Conclusions: Endoscopic laminoforaminoplasty appears to be a safe alternative to open decompression in patients with spinal foraminal stenosis; additional controlled trials are warranted.</p> ]]></description>  
<dc:creator>Scott M.W. Haufe, Anthony R. Mork, Morgan A. Pyne, Ryan A. Baker</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>2</prism:number> 
<prism:startingPage>102</prism:startingPage> 
<prism:endingPage>105</prism:endingPage> 
<pubDate>2009-3-22</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0093.htm</link> 
<title>PKC and PKA Phosphorylation Affect the Subcellular Localization of Claudin-1 in Melanoma Cells</title> 
<description><![CDATA[ <p>Cytoplasmic expression of claudin-1 in metastatic melanoma cells correlates to increased migration, and increased secretion of MMP-2 in a PKC dependent manner, whereas claudin-1 nuclear expression is found in benign nevi. Melanoma cells were transfected with a vector expressing CLDN-1 fused to a nuclear localization signal (NLS). Despite significant nuclear localization of claudin-1, there was still transport of claudin-1 to the cytoplasm. Phorbol ester treatment of cells transfected with NLS-claudin-1 resulted in an exclusion of claudin-1 from the nucleus, despite the NLS. To ascertain whether PKC or PKA were involved in this translocation, we mutated the putative phosphorylation sites within the protein. We found that mutating the PKC phosphorylation sites to mimic a non-phosphorylated state did not cause a shift of claudin-1 to the nucleus of the cells, but mutating the PKA sites did. Mutations of either site to mimic constitutive phosphorylation resulted in cytoplasmic claudin-1 expression. Stable claudin-1 transfectants containing non-phosphorylatable PKA sites exhibited decreased motility. These data imply that subcellular localization of claudin-1 can be controlled by phosphorylation, dicating effects on metastatic capacity.</p> ]]></description>  
<dc:creator>Amanda D. French, Jennifer L. Fiori, Tura C. Camilli, Poloko D. Leotlela, Michael P. O'Connell, Brittany P. Frank, Sarah Subaran, Fred. E. Indig, Dennis D. Taub, Ashani T. Weeraratna</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>2</prism:number> 
<prism:startingPage>93</prism:startingPage> 
<prism:endingPage>101</prism:endingPage> 
<pubDate>2009-3-12</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0085.htm</link> 
<title>Induction and effector phase of allergic lung inflammation is independent of CCL21/CCL19 and LT-beta</title> 
<description><![CDATA[ <p>The chemokines CCL21 and CCL19, and cell bound TNF family ligand lymphotoxin beta (LT&#946;), have been associated with numerous chronic inflammatory diseases. A general role in chronic inflammatory diseases cannot be assumed however; in the case of allergic inflammatory disease, CCL21/CCL19 and LT&#946; have not been associated with the induction, recruitment, or effector function of Th2 cells nor dendritic cells to the lung. We have examined the induction of allergic inflammatory lung disease in mice deficient in CCL21/CCL19 or LT&#946; and found that both kinds of mice can develop allergic lung inflammation. To control for effects of priming differences in knockout mice, adoptive transfers of Th2 cells were also performed, and they showed that such effector cells had equivalent effects on airway hyper-responsiveness in both knockout background recipients. Moreover, class II positive antigen presenting cells (B cells and CD11c+ dendritic cells) showed normal recruitment to the peribronchial spaces along with CD4 T cells. Thus, the induction of allergic responses and recruitment of both effector Th2 cells and antigen presenting cells to lung peribronchial spaces can develop independently of CCL21/CCL19 and LT&#946;.</p> ]]></description>  
<dc:creator>Corinne Ploix, Riaz I. Zuberi, Fu-Tong Liu, Monica J. Carson, David D. Lo</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>2</prism:number> 
<prism:startingPage>85</prism:startingPage> 
<prism:endingPage>92</prism:endingPage> 
<pubDate>2009-3-10</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0077.htm</link> 
<title>Relationship between anal symptoms and anal findings</title> 
<description><![CDATA[ <p><b>Background:</b> The frequencies and types of anal symptoms were compared with the frequencies and types of benign anal diseases (BAD).</p> <p><b>Methods:</b> Patients transferred from GPs, physicians or gynaecologists for anal and/or abdominal complaints/signs were enrolled and asked to complete a questionnaire about their symptoms. Proctologic assessment was performed in the knee-chest position. Definitions of BAD were tested in a two year pilot study. Findings were entered into a PC immediately after the assessment of each individual.</p> <p><b>Results:</b> Eight hundred seven individuals, 539 (66.8%) with and 268 without BAD were analysed. Almost one third (31.2%) of patients with BAD had more than one BAD. Concomitant anal findings such as skin tags were more frequently seen in patients with than without BAD (&#60;0.01). After haemorrhoids (401 patients), pruritus ani (317 patients) was the second most frequently found BAD. The distribution of stages in 317 pruritus ani patients was: mild (91), moderate (178), severe (29), and chronic (19). Anal symptoms in patients with BAD included: bleeding (58.6%), itch (53.7%), pain (33.7%), burning (32.9%), and soreness (26.6%). Anal lesions could be predicted according to patients' answers in the questionnaire: haemorrhoids by anal bleeding (p=0.032), weeping (p=0.017), and non-existence of anal pain (p=0.005); anal fissures by anal pain (p=0.001) and anal bleeding (p=0.006); pruritus ani by anal pain (p=0.001), itching (p=0.001), and soreness (p=0.006).</p> <p><b>Conclusions: </b>The knee-chest position may allow for the accumulation of more detailed information about BAD than the left lateral Sims' position, thus enabling physicians to make more reliable anal diagnoses and provide better differentiated therapies.</p> ]]></description>  
<dc:creator>Hans Georg Kuehn, Ole Gebbensleben, York Hilger, Henning Rohde</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>2</prism:number> 
<prism:startingPage>77</prism:startingPage> 
<prism:endingPage>84</prism:endingPage> 
<pubDate>2009-3-6</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0072.htm</link> 
<title>High-intensity non-invasive positive pressure ventilation for stable hypercapnic COPD</title> 
<description><![CDATA[ <p><b>Background:</b> The objective of the present analysis is to describe the outcomes of high-intensity non-invasive positive pressure ventilation (NPPV) aimed at maximally decreasing PaCO<sub>2</sub> as an alternative to conventional NPPV with lower ventilator settings in stable hypercapnic COPD patients.</p> <p><b>Methods:</b> Physiological parameters, exacerbation rates and long-term survival were assessed in 73 COPD patients (mean FEV<sub>1</sub> 30&#177;12 %predicted) who were established on high-intensity NPPV due to chronic hypercapnic respiratory failure between March 1997 and May 2006.</p> <p><b>Results:</b> Controlled NPPV with breathing frequencies of 21&#177;3 breath/min and mean inspiratory/expiratory positive airway pressures of 28&#177;5/5&#177;1 cmH<sub>2</sub>O led to significant improvements in blood gases, lung function and hematocrit after two months. Only sixteen patients (22%) required hospitalisation due to exacerbation during the first year, with anaemia increasing the risk for exacerbation. Two- and five-year survival rates of all patients were 82% and 58%, respectively. The five year survival rate was 32% and 83% in patients with low (&#8804;39%) and high (&#8805;55%) hematocrit, respectively.</p> <p><b>Conclusion:</b> High-intensity NPPV improves blood gases, lung function and hematocrit, and is also associated with low exacerbation rates and a favourable long-term outcome. The current report strongly emphasises the need for randomised controlled trials evaluating the role of high-intensity NPPV in stable hypercapnic COPD patients.</p> ]]></description>  
<dc:creator>Wolfram Windisch, Moritz Haenel, Jan H Storre, Michael Dreher</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>2</prism:number> 
<prism:startingPage>72</prism:startingPage> 
<prism:endingPage>76</prism:endingPage> 
<pubDate>2009-2-27</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0065.htm</link> 
<title>Esterified Hyaluronic Acid and Autologous Bone in the Surgical Correction of the Infra-Bone Defects</title> 
<description><![CDATA[ <p>We study the osteoinductive effect of the hyaluronic acid (HA) by using an esterified low-molecular HA preparation (EHA) as a coadjuvant in the grafting processes to produce bone-like tissue in the presence of employing autologous bone obtained from intra-oral sites, to treat infra-bone defects without covering membrane.</p> <p>We report on 9 patients with periodontal defects treated by EHA and autologous grafting (4 males and 5 females, all non smokers, with a mean age of 43,8 years for females, 40,0 years for males and 42 years for all the group, in good health) with a mean depth of 8.3 mm of the infra-bone defects, as revealed by intra-operative probes. Data were obtained at baseline before treatment and after 10 days, and subsequently at 6,9, and 24 months after treatment.</p> <p>Clinical results showed a mean gain hi clinical attachment (<i>gCAL)</i> of 2.6mm of the treated sites, confirmed by radiographic evaluation. Such results suggest that autologous bone combined with EHA seems to have good capabilities in accelerating new bone formation in the infra-bone defects.</p> ]]></description>  
<dc:creator>Andrea BALLINI, Stefania CANTORE, Saverio CAPODIFERRO, Felice Roberto GRASSI</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>2</prism:number> 
<prism:startingPage>65</prism:startingPage> 
<prism:endingPage>71</prism:endingPage> 
<pubDate>2009-2-26</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0051.htm</link> 
<title>Transcriptome analysis of murine thymocytes reveals age-associated changes in thymic gene expression</title> 
<description><![CDATA[ <p>The decline in adaptive immunity, na&#239;ve T-cell output and a contraction in the peripheral T cell receptor (TCR) repertoire with age are largely attributable to thymic involution and the loss of critical cytokines and hormones within the thymic microenvironment. To assess the molecular changes associated with this loss of thymic function, we used cDNA microarray analyses to examine the transcriptomes of thymocytes from mice of various ages ranging from very young (1 month) to very old (24 months). Genes associated with various biological and molecular processes including oxidative phosphorylation, T- and B- cell receptor signaling and antigen presentation were observed to significantly change with thymocyte age. These include several immunoglobulin chains, chemokine and ribosomal proteins, annexin A2, vav 1 and several S100 signaling proteins. The increased expression of immunoglobulin genes in aged thymocytes could be attributed to the thymic B cells which were found to be actively producing IgG and IgM antibodies. Upon further examination, we found that purified thymic T cells derived from aged but not young thymi also exhibited IgM on their cell surface suggesting the possible presence of auto-antibodies on the surface thymocytes with advancing age. These studies provide valuable insight into the cellular and molecular mechanisms associated with thymic aging.</p> ]]></description>  
<dc:creator>Ana Lustig, Arnell Carter, Dorothy Bertak, Divya Enika, Bolormaa Vandanmagsar, William Wood, Kevin G. Becker, Ashani T. Weeraratna, Dennis D. Taub</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>1</prism:number> 
<prism:startingPage>51</prism:startingPage> 
<prism:endingPage>64</prism:endingPage> 
<pubDate>2009-2-9</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0043.htm</link> 
<title>Multivariate explanatory model for sporadic carcinoma of the colon in Dukes' stages I and IIa</title> 
<description><![CDATA[ <p><b>Objective</b>: We obtained before an explanatory model with six dependant variables: age of the patient, total cholesterol (TC), HDL cholesterol (HDL-C), VLDL cholesterol (VLDL-C), alkaline phosphatase (AP) and the CA 19.9 tumour marker. Our objective in this study was to validate the model by means of the acquisition of new records for an additional analysis.</p> <p><b>Design: </b>Non-paired case control study.</p> <p><b>Setting: </b>Urban and rural hospitals and primary health facilities in Western Andalusia and Extremadura (Spain).</p> <p><b>Patients:</b> At both the primary care facilities and hospital level, controls were gathered in a prospective manner (n= 275). Cases were prospective and retrospective manner collected on (n=126).</p> <p><b>Main outcome measures</b>: Descriptive statistics, logistic regression and bootstrap analysis.</p> <p><b>Results: </b>The AGE (odds ratio 1.02; 95% CI 1.003-1.037) (p= 0.01), the TC (odds ratio 0.986; 95% C.I. 0.980-0.992) (p&#60; 0.001) and the CA 19.9 (odds ratio 1.023; 95% C.I. 1.012- 1.034) (p&#60;0.001) were the variables that showed significant values at logistic regression analysis and bootstrap. Berkson's bias was statistically assessed.</p> <p><b>Conclusions: </b>The model, validated by means of logistic regression and bootstrap analysis, contains the variables AGE, TC, and CA 19.9 (three of the original six) and has a level 4 over 5 according to the criteria of Justice et al. (multiple independent validations) [Ann. Intern. Med.1999; 130: 515].</p> ]]></description>  
<dc:creator>J.M. Villadiego-S&#225;nchez, M. Ortega-Calvo, R. Pino-Mej&#237;as, A. Cayuela, P. Iglesias-Bonilla, F. Garc&#237;a-de la Corte, J.M. Santos-Lozano, Jos&#233; Lapetra-Peralta</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>1</prism:number> 
<prism:startingPage>43</prism:startingPage> 
<prism:endingPage>50</prism:endingPage> 
<pubDate>2009-1-30</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0037.htm</link> 
<title>Continuous Non-Invasive Arterial Pressure Technique Improves Patient Monitoring during Interventional Endoscopy</title> 
<description><![CDATA[ <p><b>Introduction</b>: Close monitoring of arterial blood pressure (BP) is a central part of cardiovascular surveillance of patients at risk for hypotension. Therefore, patients undergoing diagnostic and therapeutic procedures with the use of sedating agents are monitored by discontinuous non-invasive BP measurement (NIBP). Continuous non-invasive BP monitoring based on vascular unloading technique (CNAP&#174;, CN Systems, Graz) may improve patient safety in those settings. We investigated if this new technique improved monitoring of patients undergoing interventional endoscopy.</p> <p><b>Methods</b>: 40 patients undergoing interventional endoscopy between April and December 2007 were prospectively studied with CNAP&#174; in addition to standard monitoring (NIBP, ECG and oxygen saturation). All monitoring values were extracted from the surveillance network at one-second intervals, and clinical parameters were documented. The variance of CNAP&#174; values were calculated for every interval between two NIBP measurements.</p> <p><b>Results</b>: 2660 minutes of monitoring were recorded (mean 60.1&#177;34.4 min/patient). All patients were analgosedated with midazolam and pethidine, and 24/40 had propofol infusion (mean 90.9&#177;70.3 mg). The mean arterial pressure for CNAP&#174; was 102.4&#177;21.2 mmHg and 106.8&#177;24.8 mmHg for NIBP. Based on the first NIBP value in an interval between two NIBP measurements, BP values determined by CNAP&#174; showed a maximum increase of 30.8&#177;21.7% and a maximum decrease of 22.4&#177;28.3% (mean of all intervals).</p> <p><b>Discussion</b>: Conventional intermittent blood pressure monitoring of patients receiving sedating agents failed to detect fast changes in BP. The new technique CNAP&#174; improved the detection of rapid BP changes, and may contribute to a better patient safety for those undergoing interventional procedures.</p> ]]></description>  
<dc:creator>Sylvia Siebig, Felix Rockmann, Karl Sabel, Ina Zuber-Jerger, Christine Dierkes, Tanja Br&#252;nnler, Christian E. Wrede</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>1</prism:number> 
<prism:startingPage>37</prism:startingPage> 
<prism:endingPage>42</prism:endingPage> 
<pubDate>2009-1-20</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0028.htm</link> 
<title>Sustained High Quality of Life in a 5-Year Long Term Follow-up after Successful Ablation for Supra-Ventricular Tachycardia. Results from a large Retrospective Patient Cohort</title> 
<description><![CDATA[ <p><b><i>Introduction: </i></b>The ablation of supraventricular tachycardias (SVT) using radiofrequency energy (RF) is a procedure with a high primary success rate. However, there is a scarcity of data regarding the long term outcome, particularly with respect to quality of life (QoL).</p> <p><b><i>Methods and Results: </i></b>In this retrospective single-center study, 454 patients who underwent ablation of SVT between 2002 and 2007 received a detailed questionnaire addressing matters of QoL. The questionnaire was a modified version of the SF-36 Health Survey questionnaire and the Symptom Checklist &#8211; Frequency and Severity Scale.</p> <p>After a mean follow up of 4.5&#177;1.3 years, 309 (68.1%) of the contacted 454 patients (269 female, 59.2%, mean age 58+/-6.5) completed the questionnaire. Despite of 27% of relapses in the study group, 91.7% considered the procedure a long-term success. The remainder of patients experienced no change in (3.7%) or worsening of (4.7%) symptoms. There were no significant differences between the various types of SVT (p=1). QoL in patients with Atrio-Ventricular Nodal Reentry Tachycardia (AVNRT) and Atrio-Ventricular Reentry Tachycardia (AVRT) improved significantly (p&#60;0.0005 respectively p&#60;0.043), whereas QoL in patients with Ectopic Atrial Tachycardia (EAT) showed a non-significant trend towards improvement. Main symptoms before ablation, such as tachycardia (91.5%), increased incidence of tachycardia episodes over time (78.1%), anxiety (55.5%) and reduced physical capacity in daily life (52%) were significantly improved after ablation (p&#60;0.0001).</p> <p><b><i>Conclusion: </i></b>The high acute ablation success of SVT persists for years in long term follow up and translates into a significant improvement of QoL in most patients.</p> ]]></description>  
<dc:creator>Axel Meissner, Irini Stifoudi, Peter Weism&#252;ller, Max-Olav Schrage, Petra Maagh, Martin Christ, Thomas Butz, Hans-Joachim Trappe, Gunnar Plehn</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>1</prism:number> 
<prism:startingPage>28</prism:startingPage> 
<prism:endingPage>36</prism:endingPage> 
<pubDate>2009-1-11</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0018.htm</link> 
<title>Transporter Molecules influence the Gene Expression in HeLa Cells</title> 
<description><![CDATA[ <p>Progresses in biology and pharmacology led to highly specific bioactive substances, but their poor bioavailability at the site of action is a result of their physico-chemical properties. Various design approaches for transport carrier molecules facilitating the cellular entry of bioactive substances could help to reach their molecular target in cells and tissues. The transfer efficacy and the subsequent pharmacological effects of the cargo molecules are well investigated, but the investigations of effects of the carrier molecules themselves on the target cells or tissues remain necessary. A special attention should be paid to the differential gene expression, particularly in the interpretation of the data achieved by highly specific active pharmaceutical products. After application of transmembrane transport peptides, particularly the pAnt and also the HIV-1 Tat, cells respond with a conspicuous altered gene expression of at least three genes. The <i>PKN1 </i>gene was induced and two genes (<i>ZCD1 </i>and <i>BSG</i>) were slightly repressed. The genes and the chromosomes are described, the moderate differential gene expression graphed, and the ontology is listed.</p> ]]></description>  
<dc:creator>Waldemar Waldeck, Ruediger Pipkorn, Bernhard Korn, Gabriele Mueller, Matthias Schick, Katalin T&#243;th, Manfred Wiessler, Bernd Didinger, Klaus Braun</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>1</prism:number> 
<prism:startingPage>18</prism:startingPage> 
<prism:endingPage>27</prism:endingPage> 
<pubDate>2008-12-18</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0009.htm</link> 
<title>Matrix Metalloproteinase Activity in Pediatric Acute Lung Injury</title> 
<description><![CDATA[ <p>Pediatric Acute Lung Injury (ALI) is associated with a high mortality and morbidity, and dysregulation of matrix metalloproteinases (MMPs) may play an important role in the pathogenesis and evolution of ALI. Here we examined MMP expression and activity in pediatric ALI compared with controls. MMP-8, -9, and to a lesser extent, MMP-2, -3, -11 and -12 were identified at higher levels in lung secretions of pediatric ALI patients compared with controls. Tissue Inhibitor of Matrix metalloproteinase-1 (TIMP-1), a natural inhibitor of MMPs was detected in most ALI samples, but MMP-9:TIMP-1 ratios were high relative to controls. In subjects who remained intubated for &#8805;10 days, MMP-9 activity decreased, with &#62; 80% found in the latent form. In contrast, almost all MMP-8 detected at later disease course was constitutively active. Discriminating MMP-9:TIMP-1 ratios were found in those who had a prolonged ALI course. These results identify a specific repertoire of MMP isoforms in the lung secretions of pediatric ALI patients, and demonstrate inverse changes in MMPs -8 and -9 with protracted disease.</p> ]]></description>  
<dc:creator>Michele YF Kong, Amit Gaggar, Yao Li, Margaret Winkler, J Edwin Blalock, JP Clancy</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>1</prism:number> 
<prism:startingPage>9</prism:startingPage> 
<prism:endingPage>17</prism:endingPage> 
<pubDate>2008-12-16</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v06p0001.htm</link> 
<title>Evaluation of Fractional Analysis of Bronchoalveolar Lavage Combined with Cellular Morphological Features</title> 
<description><![CDATA[ <p><b>Background.</b> The value of bronchoalveolar lavage (BAL) still remains controversial, prompting a need for further improvement. The purpose of this study was to develop and evaluate a sequential analysis of cell content in fractional BAL (FBAL) from the airways and alveolar sacs with incorporation of the cellular morphologic features. <b>Methods.</b> Initially, 30 ml saline was infused into a subsegmental lobe of the lung and the recovered fluid was assigned as FBAL-I being mainly originated from whole airways. The second and third lavages (FBAL-II and FBAL-III) each were performed using 50 ml saline being from more distal portions of airways and alveolar sacs respectively in the same lobe. Total cell number/ml and percentages of macrophages, lymphocytes, neutrophils, and eosinophils in each fraction together with their morphological alterations and mast cells, basophils and Masson bodies were assessed. <b>Results.</b> In the 12 controls, percentage of neutrophils was high and lymphocytes and macrophages were low in FBAL-I while in FBAL-III, neutrophils decreased to nearly nil and lymphocytes and macrophages were increased. Analysis of FBAL from 76 patients with sarcoidosis and 14 with hypersensitivity pneumonitis (HP) revealed that a predominance of small, round and well-differentiated lymphocytes with relative absence of neutrophils, basophils and Masson bodies correlated best with sarcoidosis. In contrast, neutrophil predominance and presence of lymphocytes having deep nuclear indentations and abundant cytoplasm with a process resembling a &#8220;hand-mirror&#8221; correlated well with HP. <b>Conclusions.</b> Evaluation of FBAL together with cellular morphological features especially characteristics of lymphocytes provides valuable information for establishing the diagnosis in interstitial lung diseases.</p> ]]></description>  
<dc:creator>Namiko Taniuchi, Mohammad Ghazizadeh, Tatsuji Enomoto, Kiyoshi Matsuda, Masashi Sato, Yuko Takizawa, Enjing Jin, Seiko Egawa, Arata Azuma, Akihiko Gemma, Shoji Kudoh, Oichi Kawanami</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>6</prism:volume> 
<prism:number>1</prism:number> 
<prism:startingPage>1</prism:startingPage> 
<prism:endingPage>8</prism:endingPage> 
<pubDate>2008-12-1</pubDate>
<category>Research Paper</category>
</item>

<atom:link href="http://www.medsci.org/rss/v6.xml" rel="self" type="application/rss+xml" />
</channel>
</rss>
